{
  "retracted": false,
  "timestamp": 1577836800000,
  "updates": [
    {
      "timestamp": 1591703399656,
      "identifier": {
        "doi": "10.1212/nxi.0000000000000650"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/nxi.0000000000000631"
  },
  "journal": "Neurology - Neuroimmunology Neuroinflammation",
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis"
}
